11.3 C
Munich

Jose Baselga, who advanced breast cancer treatment, has died at the age of 61

José Baselga was born in Barcelona on July 3, 1959 and received his medical degree from the Autonomous University of Barcelona. He attracted the attention of cancer researchers at the Memorial Sloan Kettering Medical Scholarship, where he worked with Dr. Mend on Mendelssohn to study the use of monoclonal antibodies to target certain proteins associated with aggressive cancers, including lung and breast cancer.

Dr. Larry Norton, Senior Vice President of Memorial Sloan Kettering բժշկական Medical Director of Evelyn H. Lauder Hospital Breast Center, quickly became interested in Dr. Baselga և and served as an early mentor. “He was an artist,” Dr. Norton recalled, adding that he “has the motivation to focus all he needs to make that vision happen.”

Dr. Baselga returned to Spain in 1996 to establish the Val d’Hebron Oncology Institute at the Val d’Ebro University Hospital in Barcelona. Under his leadership, the center became a powerful international center for cancer research, providing targeted therapies in early clinical trials. Dr. Baselga became famous in Spain.

“Spain was not known around the world as a cancer research site,” said Dr. Anthony Ribas, president of the American Cancer Research Association, who spent his medical in Val d’Hebron before Dr. Baselga worked there. “He put Vall d’Hebron, Barcelona and Spain on the map of cancer research.”

At Massachusetts General Hospital, where he was head of the Department of Hematology and Oncology, after practicing from 2010 to 2013, Dr. Baselga returned to the Sloan Kettering Memorial, becoming chief physician in 2013 and later chief medical officer.

He has had several leading roles in the world of cancer research, including being president of the American Cancer Research Association and editor of other medical journals, Cancer Detection.

Dr. Baselgaվեց dismissed Sloan Kettering in September 2018 under pressure after The Times P ProPublica, a non-commercial investigative journalism outfit, reported that he had failed to disclose millions of dollars in payments և to drug companies The The New in dozens of research articles. English Medical Journal և Other publications.

LEAVE A REPLY

Please enter your comment!
Please enter your name here